Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resistance-Optimised Antimicrobial Dosing in Critically Ill Patients, a Randomised Controlled Trial

NCT07820501 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT07820501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07820501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resistance-Optimised Antimicrobial Dosing in Critically Ill Patients, a Randomised Controlled Trial
Lead sponsor
The University of Queensland
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
September 30, 2029
Enrollment
610 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, hospital-acquired pneumonia (hap), nosocomial respiratory infection, ventilator-associated pneumonia (vap)